Key Takeaway
Before any peptide protocol, pull a 22-marker baseline: IGF-1, full hormone panel, CBC, CMP, fasting glucose and HbA1c, lipids, hsCRP, and vitamin D. Expect to pay $200 to $400 direct-to-consumer at LabCorp or Quest. Repeat at 6 to 8 weeks, then every 3 to 6 months.
Peptides get sold like supplements, but they push real biology. GH-releasing peptides move IGF-1 and can shift hematocrit. MK-677 raises fasting insulin and HbA1c. BPC-157 and TB-500 are cleared by liver and kidney. If you start a protocol without baseline labs, you have no way to tell what the peptide did, what was already off, and whether something quiet is getting worse.
This is the panel FormBlends clinicians want to see before signing off on any peptide prescription. You can order most of these yourself.
Why baseline labs matter before any peptide
Baseline labs give you a before picture. Without one, you cant separate peptide effects from existing problems, and you cant prove a benefit to anyone including yourself. You also miss contraindications. Elevated hematocrit, untreated thyroid disease, active liver dysfunction, and undiagnosed prediabetes all change what peptides are safe to run.
The second reason is dose titration. A man with a baseline IGF-1 of 210 ng/mL starting sermorelin has a completely different ceiling than one starting at 95 ng/mL. The 210 patient needs less peptide and tighter monitoring. The 95 patient has room to climb. You cannot make that call without the number.
Third is legal and clinical cover. Any licensed prescriber running peptides through a 503A or 503B pharmacy needs documented labs to justify the script. No labs, no legitimate prescription. That is the line between a compounded medication and a gray market research chemical.
The complete 22-marker panel explained
The panel below covers every peptide class FormBlends clinicians prescribe: GH secretagogues (CJC-1295, ipamorelin, sermorelin, tesamorelin, MK-677), healing peptides (BPC-157, TB-500), metabolic peptides (semaglutide, tirzepatide), and melanocortins (PT-141). If you skip markers, you skip safety signals.
| Marker | Typical reference range | Why it matters |
|---|---|---|
| IGF-1 | Age-adjusted, roughly 90 to 250 ng/mL | Baseline and target for all GH peptides |
| IGFBP-3 | 3.3 to 6.7 mg/L | Context for IGF-1 bioavailability |
| Total testosterone | 264 to 916 ng/dL (men) | Peptides can blunt or stimulate HPG axis |
| Free testosterone | 6.8 to 21.5 pg/mL (men) | Bioavailable fraction, tracks symptoms better |
| LH | 1.7 to 8.6 mIU/mL (men) | Primary vs secondary hypogonadism |
| FSH | 1.5 to 12.4 mIU/mL (men) | Pituitary output context |
| Estradiol (sensitive) | 10 to 40 pg/mL (men) | Aromatization baseline |
| DHEA-S | Age-adjusted, roughly 100 to 500 ug/dL | Adrenal reserve |
| Cortisol (AM) | 6.2 to 19.4 ug/dL at 7 to 10 am | HPA axis baseline |
| Prolactin | 4 to 15.2 ng/mL (men) | Pituitary pathology screen |
| TSH | 0.45 to 4.5 uIU/mL | Thyroid status shifts response to GH peptides |
| Free T4 | 0.82 to 1.77 ng/dL | Active thyroid hormone |
| Free T3 | 2.0 to 4.4 pg/mL | Peripheral conversion check |
| Fasting insulin | 2.6 to 24.9 uIU/mL | MK-677 raises this materially |
| Fasting glucose | 70 to 99 mg/dL | Metabolic baseline |
| HbA1c | Under 5.7% | 90-day average glycemic load |
| CBC with diff | Hematocrit 38.3 to 48.6% (men) | GHRPs and testosterone both affect HCT |
| CMP (AST, ALT, BUN, Cr, eGFR, lytes) | eGFR over 60, ALT under 45 U/L | Clearance organs |
| Lipid panel | LDL under 100 mg/dL, HDL over 40 mg/dL | GH peptides can shift lipids |
| hsCRP | Under 1.0 mg/L low risk | Systemic inflammation baseline |
| Homocysteine | Under 10.4 umol/L | Methylation and vascular risk |
| Vitamin D 25-OH | 30 to 100 ng/mL | Bone and immune baseline |
| Vitamin B12 | 232 to 1245 pg/mL | Energy and neuro baseline |
Optional add-ons that clinicians often pull: ferritin, SHBG, PSA for men 40 and up, and RBC magnesium. PSA matters if youre combining peptides with testosterone therapy. SHBG explains why free T and total T sometimes disagree.
Peptide-specific labs: why IGF-1 is the master number for GH peptides
If youre running any growth hormone releasing peptide, IGF-1 is the single most informative number you own. Sermorelin, CJC-1295, ipamorelin, tesamorelin, and MK-677 all work by lifting endogenous GH pulses. GH itself is pulsatile and nearly impossible to measure on a single blood draw. IGF-1 integrates that pulse output over days, which is why every serious protocol titrates to an IGF-1 target, not to a milligram dose.
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.
Try the BMI Calculator →The usual target is the upper third of the age-adjusted reference range. For a 40-year-old man that is roughly 170 to 240 ng/mL. Pushing IGF-1 above the top of the range chronically is associated with insulin resistance and, in some observational work, cancer risk. Keeping it inside the physiologic envelope is the whole point of using a secretagogue instead of exogenous HGH.
Hematocrit matters for GHRPs and for anyone stacking with testosterone. Over 52 or 54% is a hard stop in most clinics. For MK-677 specifically, fasting insulin and HbA1c are the watchdogs. MK-677 reliably bumps both, and you want to know your starting point before anything changes.
Fasting and timing requirements
Lipids, fasting glucose, and fasting insulin need a true 10 to 12 hour fast. Water only. Coffee with cream will invalidate the insulin number. Most patients schedule the draw for 7 to 9 am, eat dinner by 8 pm the night before, and skip breakfast.
Morning timing matters for more than fasting. Cortisol and testosterone both peak in the early morning and drift down through the day. A total testosterone drawn at 4 pm will read 20 to 30% lower than the same patient at 8 am. The standard window is 7 to 10 am. Draws outside that window need a note on the chart, and any borderline result should be rechecked at the correct time before you treat.
Two quieter rules. Skip biotin supplements for 72 hours before the draw. Biotin interferes with thyroid and hormone immunoassays and produces false readings. And if youre already on any hormone replacement or peptide, tell the lab and the ordering clinician. Timing the draw at trough vs peak changes everything.
How to order labs without a doctor
You have three realistic paths. The cheapest is direct-to-consumer through companies that use LabCorp or Quest as the fulfillment lab. Marek Health, Ulta Lab Tests, Own Your Labs, and Quest's own MyQuest consumer portal all let you buy a peptide or hormone panel, walk into a draw station, and get results in 3 to 5 days. Expect $200 to $400 for the full 22-marker panel.
The middle path is a concierge or longevity clinic that bundles labs, a consult, and sometimes the prescription. Pricing runs $400 to $800 for labs alone, more with the consult. You pay more, but you get someone to interpret the results and write the script if indicated.
The third path is FormBlends itself. If youre starting a peptide with us, the intake flow pulls the required baseline labs at contracted LabCorp pricing and a licensed clinician reviews them before writing. That review is where IGF-1, hematocrit, and liver enzymes get flagged if theyre out of range. See our full provider and product lineup in the directory, or jump straight to an intake on the start page.
Reading your results without freaking out
Reference ranges are not treatment targets. A total testosterone of 280 ng/dL is technically in range, and also low enough to cause clinical symptoms in most men. An IGF-1 of 240 is in range for a 25-year-old and high for a 55-year-old. Always look at the age-adjusted column, not the global reference.
Out-of-range flags need context, not panic. A single elevated ALT after a hard weekend of drinking or heavy lifting does not mean liver disease. An hsCRP of 8 two days after dental work does not mean chronic inflammation. Repeat any suspicious value under clean conditions before you change a protocol. Trends across three draws matter more than any one data point.
When you do see a real problem, the clinical question is never just peptide dose. Its whether the peptide is safe to run at all. Elevated hematocrit pauses GHRPs. Fasting glucose over 110 rules out MK-677. ALT over twice the upper limit pauses everything until you know why. Track your numbers over time in the progress tracker so trends are obvious.
When to repeat labs
The standard cadence for most FormBlends peptide patients: baseline, then a recheck at 6 to 8 weeks, then every 3 to 6 months while on therapy. The 6 to 8 week draw is the most important one. Thats when IGF-1 has stabilized on a new GH peptide dose, when hematocrit shifts are visible, and when any metabolic drift from MK-677 shows up on fasting insulin and HbA1c.
Some markers only need the baseline and annual recheck unless something changes. Vitamin D, B12, TSH, and the full hormone panel fall in this bucket for most patients. CBC, CMP, IGF-1, fasting glucose, insulin, and HbA1c cycle more often because peptides can move them on a 4 to 12 week timescale.
If you change peptides, change doses meaningfully, or start a stack, reset the clock. A new 6 to 8 week draw is the rule. For related reading, see IGF-1 testing: when and how to time the draw and Peptide safety monitoring: the full schedule by compound.
Frequently asked questions
Do I really need all 22 markers if Im only running BPC-157?
You can get away with a lighter panel for oral or subcutaneous BPC-157 alone. CBC, CMP, lipids, hsCRP, and vitamin D are the minimum. The full 22 is standard if youre also considering a GH peptide, testosterone, or MK-677 in the next six months, which most patients eventually are.
Can I skip IGF-1 if Im not using a GH peptide?
Yes, technically. In practice we still pull it because patients frequently add a GH peptide within a few months and the baseline is much more useful than a mid-protocol first draw. It also doubles as a rough health-span marker.
Whats the cheapest way to get this panel?
Direct-to-consumer through a LabCorp or Quest partner runs $200 to $400 depending on which add-ons you include. Ulta Lab Tests and Marek Health are two of the commonly used aggregators. Insurance almost never covers peptide-related labs unless theres a documented medical indication.
Do I need to stop my current supplements before the draw?
Stop biotin for at least 72 hours. Biotin tanks the accuracy of thyroid and hormone immunoassays. Keep everything else, but list what youre on for the clinician. DHEA supplementation will inflate DHEA-S. Ashwagandha can shift cortisol.
How long do results take?
LabCorp and Quest turn most of the panel in 2 to 4 business days. Sensitive estradiol and free T by equilibrium dialysis can take 5 to 7 days because they run at specific reference labs. Plan your protocol start date accordingly.
Can I use a home finger-stick test instead?
For HbA1c, vitamin D, and some lipid panels, yes. For IGF-1, hormones, CBC, and CMP, no. Those need a venous draw, and venous draws at a lab are cheap enough that home kits rarely make sense for a full peptide baseline.
What if my baseline is already out of range?
Depends on which marker. Low testosterone, low vitamin D, or low B12 are things to fix before or alongside peptides. Elevated ALT, high hematocrit, or fasting glucose over 110 usually pause the peptide plan until the underlying issue is worked up. Your clinician should make that call based on the numbers and your history.
How often should women repeat these labs on peptide protocols?
Same cadence as men: baseline, 6 to 8 weeks, then every 3 to 6 months. Estradiol, progesterone, and cycle phase add complexity for premenopausal women, so the hormone panel timing should be coordinated with cycle day when possible.
Last reviewed: 2026-04-17. Medical disclaimer: This article is for educational purposes only and is not medical advice. Always consult your healthcare provider before starting any medication. Individual results vary. FormBlends is a licensed telehealth platform; nothing here replaces a personal clinical evaluation.